Gelteq Enhances Partnership with Monash Innovation Labs
Wednesday, August 07, 2024
Gelteq Limited, a global biotechnology firm specializing in ingestible gel technology, is expanding its partnership with Monash University, ranked #2 in the world for pharmaceutical science. The Company is setting up a new full-time research and development laboratory within the Monash Innovation Labs, a premier collaboration hub offering advanced scientific facilities, technical expertise, and access to STEM talent for growing businesses in Australia.
Nathan Givoni, Gelteq’s Co-Founder and Chief Executive Officer, stated, “Monash University is a premiere international research institution, and this partnership has allowed us to collaborate with top-tier researchers and innovators while also providing us access to talented students that contribute to our talent pipeline. Monash has already been an essential partner to Gelteq, providing access to dedicated state-of-the art wet labs to conduct R&D. We are pleased to strengthen our existing partnership and continue to grow our company on a global scale with the support offered through this collaboration.”
By being based at Monash Innovation Labs, Gelteq will streamline its manufacturing processes and benefit from Monash’s advanced analytical testing labs, allowing for efficient product development from conception to production while ensuring compliance with regulatory standards.
Professor Adrian Neild, Director of the Monash Innovation Labs and Deputy Dean (Strategic Initiatives) in the Faculty of Engineering at Monash University, stated, “We are pleased to partner with Gelteq and welcome the company into the Monash Innovation Labs community. Gelteq are at the forefront of medical delivery technology and we look forward to seeing the outcomes of their groundbreaking research and the mutual benefits of partnering with our STEM student talent.”
Source: globenewswire.com
